Consolidated Statement of Changes in Equity (Deficit) - USD ($) $ in Thousands	Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Treasury Stock [Member]	Noncontrolling Interest [Member]	Total
Beginning balance at Dec. 31, 2020	$ 2,537	$ 64	$ 87,570	$ (88,275)		$ (2,369)	$ (473)
Beginning balance, shares at Dec. 31, 2020	1,228,075	63,819,935
Dividends declared - Series B Convertible Preferred Stock	$ 288			(288)
Dividends declared - series B convertible preferred stock, shares	96,292
Conversions - Series B Convertible Preferred Stock	$ (406)		406
Conversions - Series B Convertible Preferred Stock, shares	(210,448)	210,448
Vest - restricted stock awards
Vest - restricted stock awards, shares		150,000
Exercise - Series Z warrants		$ 5	7,799				7,804
Exercise - Series Z warrants, shares		4,877,484
Conversions - Senior Secured Convertible Note		$ 1	1,722				1,723
Conversions - Senior Secured Convertible Note, shares		667,668
Exercise - stock options			979				979
Exercise - stock options, shares		621,164
Purchase - Employee Stock Purchase Plan			436				436
Purchase - Employee Stock Purchase Plan, shares		234,592
Impact of subsidiary equity transactions			39,576			16,760	56,336
Stock-based compensation - PAVmed Inc.			5,410				5,410
Stock-based compensation - majority-owned subsidiary			465			9,134	9,599
Net Loss				(50,347)		(5,779)	(56,126)
Issue common stock – registered offerings, net		$ 16	53,688				53,704
Issue common stock - registered offerings, net, shares		15,782,609
Exercise - Series W warrants			20				20
Exercise - Series W warrants, shares		3,945
Investment in Veris Health Inc. subsidiary						6	6
Ending balance at Dec. 31, 2021	$ 2,419	$ 86	198,071	(138,910)		17,752	79,418
Ending balance, shares at Dec. 31, 2021	1,113,919	86,367,845
Dividends declared - Series B Convertible Preferred Stock	$ 276			(276)
Dividends declared - series B convertible preferred stock, shares	91,885
Conversions - Series B Convertible Preferred Stock
Conversions - Series B Convertible Preferred Stock, shares	(45)	45
Issue common stock - PAVM ATM Facility		$ 1	78				$ 79
Issue common stock - PAVM ATM Facility, shares		106,225					106,225
Vest - restricted stock awards		$ 1	(1)
Vest - restricted stock awards, shares		541,666
Exercise - Series Z warrants
Exercise - Series Z warrants, shares		5
Conversions - Senior Secured Convertible Note		$ 7	11,800				11,807
Conversions - Senior Secured Convertible Note, shares		7,189,358
Exercise - stock options			302				302
Exercise - stock options, shares		299,999
Exercise - stock options of majority-owned subsidiary						695	695
Purchase - Employee Stock Purchase Plan			218		140		358
Purchase - Employee Stock Purchase Plan, shares		194,240
Purchase - majority-owned subsidiary common stock - Employee Stock Purchase Plan						109	109
Issuance - majority-owned subsidiary common stock - Committed Equity Facility, net of financing charges						1,767	1,767
Impact of subsidiary equity transactions			(28)			28
Issuance - majority-owned subsidiary common stock - Settlement APA-RDx - Installment Payment						653	653
Stock-based compensation - PAVmed Inc.			5,666				5,666
Stock-based compensation - majority-owned subsidiary						13,866	13,866
Treasury stock					(548)		(548)
Treasury stock, shares		(188,846)
Net Loss				(88,983)		(14,255)	(103,238)
Ending balance at Dec. 31, 2022	$ 2,695	$ 95	$ 216,106	$ (228,169)	$ (408)	$ 20,615	$ 10,934
Ending balance, shares at Dec. 31, 2022	1,205,759	94,510,537